SCHEMBL24766575

SCHEMBL24766575

CCOC(=O)[C@@H]1C[C@H]1c1cc(Cl)cc(N2CCOCC2)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 2/20 0.45
▸ PIK3CA P42336 1/20 0.43
▸ TSHR P16473 2/20 0.40
▸ USP2 O75604 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ DGAT1 O75907 6/20 0.40
▸ SOAT1 P35610 6/20 0.40
▸ LGMN Q99538 1/20 0.39
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ POLB P06746 1/20 0.38
▸ KDM4E B2RXH2 3/20 0.37
▸ GAA P10253 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ HPGD P15428 2/20 0.37
▸ GLA P06280 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24766540 1.00 AKT1 (0.45) AKT1PIK3CATSHRUSP2TDP1
SCHEMBL29434079 0.83 MAPT (0.41) AKT1PIK3CATSHRUSP2TDP1
SCHEMBL29434081 0.83 MAPT (0.41) AKT1PIK3CATSHRUSP2TDP1
SCHEMBL24766573 0.75 MAPT (0.42) PIK3CATSHRUSP2TDP1NPC1
SCHEMBL24766022 0.74 AKT1 (0.46) AKT1PIK3CATSHRUSP2TDP1
SCHEMBL29434092 0.74 AKT1 (0.46) AKT1PIK3CATSHRUSP2TDP1
SCHEMBL14842201 0.72 CA1 (0.38) MEN1KMT2AL3MBTL1KDM4EGAA
SCHEMBL24766538 0.72 AKT1 (0.47) AKT1PIK3CATSHRUSP2TDP1
SCHEMBL24739780 0.71 TDP1 (0.38) TDP1MEN1KMT2AL3MBTL1KDM4E
SCHEMBL29879874 0.71 TDP1 (0.38) TDP1MEN1KMT2AL3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11407737-B2 Inhibitors of RAF kinases KINNATE BIOPHARMA INC. (US) 2022-08-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11407737-B2 Inhibitors of RAF kinases BRAF, RAF1, ARAF AKT1 38/4885PIK3CA 61/4885TSHR 1226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback